OSCR

TDP-43: [GU]-ardian of the transcriptome.

Overview

  1. Department of Neuroscience, Johns Hopkins School of Medicine, Baltimore, MD USA
  2. Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD USA
  3. Present Address: Allen Institute, WA Seattle, USA
  4. Medical Scientist Training Program, Johns Hopkins School of Medicine, Baltimore, MD USA
Institutions: Johns Hopkins University (United States); Johns Hopkins Medicine (United States); Allen Institute (United States); Johns Hopkins Hospital (United States)
Journal: Molecular neurodegeneration, volume 21, issue 1, article 34
Dates: received 9 January 2026; accepted 14 April 2026; published online 14 May 2026
Type: Review · Language: English
License: CC BY
Identifiers: DOI 10.1186/s13024-026-00944-2 · PMID 42135847 · PMCID PMC13343711 · OpenAlex W7161114406
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: genetics / omics (modality), human (organism), other condition (population), cellular / molecular (subfield)
MeSH: DNA-Binding Proteins*, Neurodegenerative Diseases*, Transcriptome*, Animals, Humans (* major topic)
Topic: Amyotrophic Lateral Sclerosis Research (Neurology, Medicine), according to OpenAlex
Funding: National Science Foundation (DGE2139757)
Citations: cited by 1 paper (Europe PMC); 670 references in the paper

Abstract

TDP-43 is a ubiquitously expressed, primarily nuclear DNA/RNA-binding protein implicated in neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Alzheimer’s disease (AD). In this review, we examine the structure and regulation of TDP-43, how these features influence its localization and functional activity, and how their disruption may contribute to disease. Among TDP-43’s diverse functions, splicing repression of nonconserved RNA sequences termed cryptic exons has emerged as especially central to human disease. TDP-43 nuclear depletion and cytoplasmic aggregation are well-established pathological features in affected neurons and glia of neurodegenerative diseases, and accumulating evidence suggests that loss of TDP-43-mediated splicing repression occurs presymptomatically in disease. Advances in RNA-sequencing have enabled systematic identification of cryptic exon inclusion as a sensitive marker of TDP-43 dysfunction. Here, we synthesize current knowledge of TDP-43 biology and curate datasets from human tissues and experimental models, focusing on cryptic splicing to provide a resource for leveraging cryptic exon biology to better understand, detect, and target TDP-43 dysfunction.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability

Data sharing is not applicable as no datasets were generated or analyzed in the article.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 5 authors, 5 MeSH terms, 1 funder, 667 references.

Cite

This paper

Sinha, I. R., Atkinson, A. L., Irwin, K. E., Ling, J. P., & Wong, P. C. (2026). TDP-43: [GU]-ardian of the transcriptome. Molecular neurodegeneration, 21(1), 34. https://doi.org/10.1186/s13024-026-00944-2

BibTeX

@article{sinha2026tdp,
author = {Sinha, Irika R and Atkinson, Abigail L and Irwin, Katherine E and Ling, Jonathan P and Wong, Philip C},
title = {{TDP-43: [GU]-ardian of the transcriptome}},
journal = {Molecular neurodegeneration},
year = {2026},
month = may,
volume = {21},
number = {1},
pages = {34},
publisher = {BMC},
issn = {1750-1326},
doi = {10.1186/s13024-026-00944-2},
url = {https://doi.org/10.1186/s13024-026-00944-2},
pmid = {42135847},
pmcid = {PMC13343711}
}

RIS

TY - JOUR
AU - Sinha, Irika R
AU - Atkinson, Abigail L
AU - Irwin, Katherine E
AU - Ling, Jonathan P
AU - Wong, Philip C
TI - TDP-43: [GU]-ardian of the transcriptome
T2 - Molecular neurodegeneration
J2 - Mol Neurodegener
PY - 2026
DA - 2026/05/14
VL - 21
IS - 1
SP - 34
SN - 1750-1326
PB - BMC
DO - 10.1186/s13024-026-00944-2
UR - https://doi.org/10.1186/s13024-026-00944-2
LA - en
ER -

CSL-JSON

{
"id": "10.1186/s13024-026-00944-2",
"type": "article-journal",
"title": "TDP-43: [GU]-ardian of the transcriptome",
"container-title": "Molecular neurodegeneration",
"author": [
{
"family": "Sinha",
"given": "Irika R"
},
{
"family": "Atkinson",
"given": "Abigail L"
},
{
"family": "Irwin",
"given": "Katherine E"
},
{
"family": "Ling",
"given": "Jonathan P"
},
{
"family": "Wong",
"given": "Philip C"
}
],
"container-title-short": "Mol Neurodegener",
"volume": "21",
"issue": "1",
"page": "34",
"DOI": "10.1186/s13024-026-00944-2",
"PMID": "42135847",
"PMCID": "PMC13343711",
"ISSN": "1750-1326",
"publisher": "BMC",
"URL": "https://doi.org/10.1186/s13024-026-00944-2",
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
14
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1126/sciadv.ady0256
Isoform-specific steric zippers drive aberrant assembly and mislocalization of shortened TDP-43.
Journal: Science advances
In common: other condition, cellular / molecular, 37 references
[2] doi:10.1016/j.neuron.2026.01.018 [code]
DCPS modulates TDP-43-linked neurodegeneration through P-body-mediated RNA decay.
Journal: Neuron
In common: other condition, cellular / molecular, 36 references
[3] doi:10.1038/s43587-026-01166-3
Therapeutic targeting of the conserved region within the low-complexity domain of TDP-43 is neuroprotective and extends survival in amyotrophic lateral sclerosis mice.
Journal: Nature aging
In common: other condition, 31 references
[4] doi:10.1038/s41467-026-70243-3 [code]
TYK2 mediates neuroinflammation in Alzheimer's disease brains with TDP-43 pathology.
Journal: Nature communications
In common: cellular / molecular, 20 references
[5] doi:10.1016/j.cell.2026.05.047 [code]
An emergent disease-associated motor neuron state precedes cell death in ALS.
Journal: Cell
In common: genetics / omics, other condition, cellular / molecular, 15 references
[6] doi:10.1038/s41467-026-69944-6 [code]
Multi-modal dissection of cell-type specific TDP-43 pathology in the motor cortex.
Journal: Nature communications
In common: genetics / omics, other condition, 14 references
[7] doi:10.1038/s41593-026-02348-3
Microglial TDP-43 mediates myelin refinement and represses Tyrobp cryptic exon inclusion in mice.
Journal: Nature neuroscience
In common: cellular / molecular, 14 references
[8] doi:10.1016/j.nbd.2026.107475
Human TDP-43 expression worsens FTD-related phenotypes in progranulin-insufficient mice.
Journal: Neurobiology of disease
In common: cellular / molecular, 13 references
[9] doi:10.1038/s41593-026-02300-5 [code]
Integrated single-cell and spatial transcriptomic profiling in ALS uncovers peripheral-to-central immune infiltration and reprogramming.
Journal: Nature neuroscience
In common: genetics / omics, other condition, cellular / molecular, 10 references
[10] doi:10.1002/alz.71267 [code]
Hippocampal subfield thickness and shape analysis in examining the impact of TDP-43 in primary age-related tauopathy.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
In common: cellular / molecular, 9 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.